600 patients66,869 observations120 daysLIVE

Patient P-01429

Synthetic patientNBL-101 · Day 115 · 45–54 · F · baseline S09Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Stable
GI state
Stable
Inflammatory state
Stable
Nutritional resilience
Improving
Discontinuation risk
56%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S09
  2. Day 49 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 60 GI-04 recommendedGI Support Protocol GI-04
  4. Day 61 Patient acceptedStarted GI-04 in the companion
  5. Day 69 GI symptom burden −32% vs expectedGI Support Protocol GI-04
  6. Day 75 Tolerance state changedUnstable → Improving

What changed?

Trajectory began diverging from predicted response on Day 49.

Primary contributors, last 14 days
  • Nutritional resilience+8
  • Inflammatory activity-3
  • Toxicity-2

What helped?

  • GI Support Protocol GI-04Day 60
    Result: symptom burden −32%
LIFE OS recommendation
Dietary Support Protocol NP-02
55%
probability of meaningful tolerance improvement
  • 284 similar trajectories
  • 66% showed improvement
  • median effect visible after 10 days

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden
Companion
53.3/100
stable · -0.5 vs previous 14 d
Toxicity
Blood
41.5/100
improving · -3.4 vs previous 14 d
Sleep quality
Wearable
17.8/100
worsening · -2.0 vs previous 14 d
Energy level
Daily log
3.3/10
stable · +0.0 vs previous 14 d
Stress level
Daily log
6/10
improving · -0.4 vs previous 14 d
Steps
Wearable
2,095
worsening · -115 vs previous 14 d
Adherence
Companion
48.6 %
stable · +0.6 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →

Heading towards restoration · 29 from the failing basin, 58 from restoration.

Good elements to keep
  • GI Support Protocol GI-04
    intervention · steering +51.1
Main detractors to watch
  • Low butyrate capacity
    hidden · steering -17.5
  • Poor metabolizer
    hidden · steering -12.7
  • Dietary fat load
    perturbation · steering -9.8
  • Simple carbohydrates
    perturbation · steering -9.2
  • Dietary fat load
    detractor · GI +5.5 next day
  • Simple carbohydrates
    detractor · GI +5.4 next day
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Dietary fat load
    +5.5detractor · 95%
  • Simple carbohydrates
    +5.4detractor · 95%
  • Spicy / capsaicin
    +1.8no signal · 39%
  • Histamine load
    +1.6no signal · 32%
  • Insoluble fibre
    +1.1no signal · 23%
  • Alcohol
    -0.3no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Butyrate / short-chain fatty acid production 80
    • MicrobiomeButyrate capacity 33/100
    • MicrobiomeF. prausnitzii depleted
    • Daily logFibre intake low in recent food logs
  • Autonomic recovery 65
    • WearableResting HR 75 bpm
    • Wearable2,095 steps/day
    • WearableShort sleep window
  • Drug metabolism and exposure 60
    • DNACYP2D6 poor metabolizer → higher exposure
    • BloodToxicity index 42
  • Inflammatory signalling 40
    • BloodInflammatory load index 55
    • WearableHRV 26 ms, trending down
  • Mucosal barrier integrity 30
    • Daily logGI symptom score 53 and rising
    • WearableSleep 5.5 h, below personal baseline
DNA
Fictional pharmacogenomic panel
  • CYP2D6 Poor metabolizer
    Higher exposure at standard dose
Microbiome
Shannon diversity 2.8 · butyrate capacity 33/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisNormal
  • Bifidobacterium longumLow
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
30 ms
Sleep
6.0 h
Steps
1,881
Resting HR
76 bpm
Daily log: GI score 53, nutritional resilience 45, adherence 49.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
  • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Track each bowel movement today: time, stool form, urgency, overnight waking
  • A 15-minute walk after lunch
  • Protect a 7.5-hour sleep window; screens off 30 minutes before
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • Electrolyte solution, one sachet after any loose stool
  • Fictional demo item: oral nutrition supplement with lunch

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0180422%S19AD-05improved61
P-0137721%S11AD-05no change42
P-0135021%S19BR-03no change34
P-0170831%S07CR-01improved59
P-0137130%S06CR-01improved63
P-0169630%S20CR-01improved59
P-0183530%S17CR-01improved56
P-0138828%S17CR-01improved59
P-0144228%S13CR-01improved61
P-0187727%S01CR-01improved67
P-0143023%S05CR-01improved54
P-0134221%S11DT-01improved48